Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92


Comparative evaluation of aggressiveness traits in staphylococcal strains from severe infections versus nasopharyngeal carriage.

Săndulescu O, Bleotu C, Matei L, Streinu-Cercel A, Oprea M, Drăgulescu EC, Chifiriuc MC, Rafila A, Pirici D, Tălăpan D, Dorobăţ OM, Neguţ AC, Oţelea D, Berciu I, Ion DA, Codiţă I, Calistru PI, Streinu-Cercel A.

Microb Pathog. 2017 Jan;102:45-53. doi: 10.1016/j.micpath.2016.11.006.


Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration - a comprehensive meeting report.

Kowalska JD, Oprea C, de Witt S, Pozniak A, Gökengin D, Youle M, Lundgren JD, Horban A; ECEE Network Group..

HIV Med. 2016 Aug 24. doi: 10.1111/hiv.12436. [Epub ahead of print]


Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.

Sperl J, Horvath G, Halota W, Ruiz-Tapiador JA, Streinu-Cercel A, Jancoriene L, Werling K, Kileng H, Koklu S, Gerstoft J, Urbanek P, Flisiak R, Leiva R, Kazenaite E, Prinzing R, Patel S, Qiu J, Asante-Appiah E, Wahl J, Nguyen BY, Barr E, Platt HL.

J Hepatol. 2016 Dec;65(6):1112-1119. doi: 10.1016/j.jhep.2016.07.050.


Bacteriophage-driven inhibition of biofilm formation in Staphylococcus strains from patients attending a Romanian reference center for infectious diseases.

Neguţ AC, Chifiriuc MC, Săndulescu O, Streinu-Cercel A, Oprea M, Drăgulescu EC, Gheorghe I, Berciu I, Coralia B, Popa M, Oţelea D, Tălăpan D, Dorobăţ O, Codiţă I, Popa MI, Streinu-Cercel A.

FEMS Microbiol Lett. 2016 Sep;363(18). pii: fnw193.


An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype.

Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Nelson M, Montaner JS, Lane HC, Larder BA; RDI Data and Study Group..

J Antimicrob Chemother. 2016 Oct;71(10):2928-37. doi: 10.1093/jac/dkw217.


Infectious diseases in perspective.

Streinu-Cercel A.

BMC Infect Dis. 2016 Mar 8;16 Suppl 1:91. doi: 10.1186/s12879-016-1395-4. No abstract available.


Prevalence of osteo-renal impairment in the Romanian HIV cohort.

Streinu-Cercel A, Săndulescu O, Ceapraga G, Manolache D, Stoica MA, Preoțescu LL, Streinu-Cercel A.

BMC Infect Dis. 2016 Mar 8;16 Suppl 1:93. doi: 10.1186/s12879-016-1397-2.


Surveillance of pneumococcal diseases in Central and Eastern Europe.

Ceyhan M, Dagan R, Sayiner A, Chernyshova L, Dinleyici EÇ, Hryniewicz W, Kulcsár A, Mad'arová L, Pazdiora P, Sidorenko S, Streinu-Cercel A, Tambić-Andrašević A, Yeraliyeva L.

Hum Vaccin Immunother. 2016 Aug 2;12(8):2124-2134.


Treatment with lamivudine and entecavir in severe acute hepatitis B.

Streinu-Cercel A, Sandulescu O, Stefan M, Streinu-Cercel A.

Indian J Med Microbiol. 2016 Apr-Jun;34(2):166-72. doi: 10.4103/0255-0857.176837.


IL-17 and IL-22 genetic polymorphisms in HBV vaccine non- and low-responders among healthcare workers.

Borzooy Z, Streinu-Cercel A, Mirshafiey A, Khamseh A, Mahmoudie MK, Navabi SS, Nosrati M, Najafi Z, Hosseini M, Jazayeri SM.

Germs. 2016 Mar 1;6(1):14-20. doi: 10.11599/germs.2016.1084.


Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.

Foster GR, Coppola C, Derbala M, Ferenci P, Orlandini A, Reddy KR, Tallarico L, Shiffman ML, Ahlers S, Bakalos G, Hassanein T; GUARD-C Study Group..

PLoS One. 2016 Mar 28;11(3):e0151703. doi: 10.1371/journal.pone.0151703.


Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen-positive chronic hepatitis B patients.

van Campenhout MJ, Brouwer WP, van Oord GW, Xie Q, Zhang Q, Zhang N, Guo S, Tabak F, Streinu-Cercel A, Wang J, Pas SD, Sonneveld MJ, de Knegt RJ, Boonstra A, Hansen BE, Janssen HL.

Clin Microbiol Infect. 2016 Jun;22(6):571.e5-9. doi: 10.1016/j.cmi.2016.02.002.


Response to "Commentary on: Microbiologic Safety of the Transareolar Approach in Breast Augmentation".

Streinu-Cercel A, Jianu DM, Săndulescu O, Streinu-Cercel A.

Aesthet Surg J. 2016 Apr;36(4):NP177. doi: 10.1093/asj/sjv264. No abstract available.


Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination.

Borzooy Z, Jazayeri SM, Mirshafiey A, Khamseh A, Mahmoudie MK, Azimzadeh P, Geravand B, Boroumand MA, Afshar M, Poortahmasebi V, Hosseini M, Streinu-Cercel A.

Germs. 2015 Dec 2;5(4):134-40. doi: 10.11599/germs.2015.1081.


Microbiologic Safety of the Transareolar Approach in Breast Augmentation.

Jianu DM, Săndulescu O, Streinu-Cercel A, Berciu I, Blidaru A, Filipescu M, Vartic M, Cobani O, Jianu ȘA, Tălăpan D, Dorobăț O, Stăniceanu F, Streinu-Cercel A.

Aesthet Surg J. 2016 Jan;36(1):51-7. doi: 10.1093/asj/sjv106.


Leptin expression in HIV-infected patients during antiretroviral therapy.

Tiliscan C, Aramă V, Mihăilescu R, Munteanu DI, Streinu-Cercel A, Ion DA, Rădulescu MA, Popescu C, Lobodan AE, Negru AR, Aramă ŞS.

Germs. 2015 Sep 1;5(3):92-8. doi: 10.11599/germs.2015.1076.


Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patients.

Brouwer WP, Sonneveld MJ, Xie Q, Guo S, Zhang N, Zeuzem S, Tabak F, Zhang Q, Simon K, Akarca US, Streinu-Cercel A, Hansen BE, Janssen HL.

J Viral Hepat. 2016 Jun;23(6):419-26. doi: 10.1111/jvh.12468.


Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.

Dore GJ, Conway B, Luo Y, Janczewska E, Knysz B, Liu Y, Streinu-Cercel A, Caruntu FA, Curescu M, Skoien R, Ghesquiere W, Mazur W, Soza A, Fuster F, Greenbloom S, Motoc A, Arama V, Shaw D, Tornai I, Sasadeusz J, Dalgard O, Sullivan D, Liu X, Kapoor M, Campbell A, Podsadecki T.

J Hepatol. 2016 Jan;64(1):19-28. doi: 10.1016/j.jhep.2015.08.015.


HIV and bone mineral density.

Streinu-Cercel A.

Germs. 2015 Mar 2;5(1):7. doi: 10.11599/germs.2015.1064. No abstract available.

Free PMC Article

Experimental approach for bacteriophage susceptibility testing of planktonic and sessile bacterial populations - Study protocol.

Neguţ AC, Săndulescu O, Popa M, Streinu-Cercel A, Alavidze Z, Berciu I, Bleotu C, Popa MI, Chifiriuc MC, Streinu-Cercel A.

Germs. 2014 Dec 1;4(4):92-6. doi: 10.11599/germs.2014.1062.

Supplemental Content

Loading ...
Support Center